Non-antibiotic drugs with the greatest observed risks for C. difficile infection were antidiarrheals, analgesics, and ...

Researchers say the reduction was influenced by the combined effects of changes in infection prevention and control, ...

Study results suggest the greatest risk for Clostridioides difficile infection was observed with use of clindamycin while the lowest risk was observed with doxycycline and minocycline. Results of the ...

Among non-antibiotic drugs, the highest risks were observed with antidiarrheals, analgesics, and corticosteroids. While ...

In a review of nearly 120,000 patients, 31% taking opioids developed C. diff, compared to 17% not taking them Opioids may weaken immunity and disrupt healthy gut bacteria, making infection more likely ...

The bacterium Clostridium difficile — otherwise known as C. diff — spreads within intensive care units more than three times as much as previously thought, according to a study published on April 4 in ...

A new comparative study led by researchers at the UNC School of Medicine found that a new therapy for prevention of recurrent Clostridioides difficile infection may be less effective than traditional ...

A new study looked at Clostridioides difficile infection (CDI) in outpatient settings and found the bacteria may be underdiagnosed, according to a study out Jan. 11 in Open Forum Infectious Diseases.

The hospital-acquired infection Clostridium difficile, which causes inflammation of the colon and can be deadly among elderly patients, may be spread outside the hospital setting via food, according ...

Recurring Clostridioides difficile infections could be costing hospitals millions, an AtlantiCare Regional Medical Center study found. The study, published Sept. 29 in Cambridge Core, included 29 ...

The prevalence of Clostridioides difficile has risen in recent years, and although its carriage is recognized in infancy, limited data exist on its longitudinal trends. Results of a large longitudinal ...

Two gastroenterologists spoke with Becker’s to discuss research challenges, advice for early-career physicians and more. Paul Feuerstadt, MD, is a practicing gastroenterologist at the ...